Enanta Pharmaceuticals Inc Capital Reinvestment Ratio
Enanta Pharmaceuticals Inc capital reinvestment ratio. Enanta Pharmaceuticals Inc (ENTA) has a Capital Reinvestment Ratio of 0.01x as of June 2025, meaning it reinvests 0% of its operating cash flow ($17.51 Million) in capital expenditures ($155.00K). Check ENTA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Enanta Pharmaceuticals Inc (2011–2020)
Capital reinvestment ratio of Enanta Pharmaceuticals Inc from 2011 to 2020. This chart tracks Enanta Pharmaceuticals Inc's Capital Reinvestment Ratio across 10 annual periods. Also explore Enanta Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Enanta Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2011–2020)
Enanta Pharmaceuticals Inc capital reinvestment ratio by year from 2011 to 2020. For the full cash flow conversion analysis, see cash flow conversion of Enanta Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.20x | $7.09 Million | $1.45 Million | ▲ +168.8% |
| 2019 | 0.08x | $71.42 Million | $5.42 Million | ▼ -25.7% |
| 2018 | 0.10x | $29.22 Million | $2.98 Million | ▲ +114.4% |
| 2017 | 0.05x | $52.65 Million | $2.51 Million | ▼ -64.0% |
| 2016 | 0.13x | $35.81 Million | $4.74 Million | ▲ +334.3% |
| 2015 | 0.03x | $76.67 Million | $2.34 Million | ▼ -40.2% |
| 2014 | 0.05x | $20.18 Million | $1.03 Million | ▼ -10.4% |
| 2013 | 0.06x | $10.65 Million | $606.00K | ▲ +410.7% |
| 2012 | 0.01x | $22.62 Million | $252.00K | ▼ -39.9% |
| 2011 | 0.02x | $24.02 Million | $445.00K | — |